PRALIDOXIME Drug Patent Profile
✉ Email this page to a colleague
When do Pralidoxime patents expire, and when can generic versions of Pralidoxime launch?
Pralidoxime is a drug marketed by Baxter Hlthcare Corp and Meridian Medcl Techn and is included in two NDAs.
The generic ingredient in PRALIDOXIME is pralidoxime chloride. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pralidoxime chloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PRALIDOXIME?
- What are the global sales for PRALIDOXIME?
- What is Average Wholesale Price for PRALIDOXIME?
Summary for PRALIDOXIME
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| DailyMed Link: | PRALIDOXIME at DailyMed |
US Patents and Regulatory Information for PRALIDOXIME
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare Corp | PRALIDOXIME CHLORIDE | pralidoxime chloride | INJECTABLE;INJECTION | 018799-001 | Dec 13, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Meridian Medcl Techn | PRALIDOXIME CHLORIDE (AUTOINJECTOR) | pralidoxime chloride | SOLUTION;INTRAMUSCULAR | 018986-001 | Apr 26, 1983 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
